CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Transcranial Magnetic Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02470377
NCT02470377N/ACompleted
CompareCT.gov

Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome

University of Minnesota·interventional·Posted Jun 12, 2015·Updated Aug 31, 2022

In Brief

A clinical study evaluating Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The goal of this study is to determine whether external neuromodulation using repetitive transcranial magnetic stimulation (rTMS) can reduce the perception of self-motion that is experienced by individuals with mal de debarquement syndrome (MdDS). Mal de debarquement is translated as the "sickness of disembarkment," and refers to the chronic feeling of rocking dizziness that occurs after exposure to passive motion. Treatment for MdDS is limited and morbidity is high. The goal of the study is to determine whether rTMS can suppress the rocking dizziness of MdDS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMal de Debarquement Syndrome
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 12, 2015
Enrollment StartAug 1, 2015
Primary CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 11.1 years ago

Interventions

Transcranial Magnetic Stimulationdevice

A form of external neuromodulation using pulsatile magnetic fields on the surface of the head.